 | • レポートコード：B-GIR08C0094 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アファチニブの世界市場について調べ、まとめました。種類別セグメントは、30mgテーブル、40mgテーブル、50mgテーブル、25mgテーブル、20mgテーブル、その他等、用途別セグメントは、肺、乳房、結腸直腸、黒色腫、前立腺、頭頸部、卵巣、膵臓等に区分しました。アファチニブの世界市場概観、企業動向、企業別アファチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アファチニブの市場概観 ・アファチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アファチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・アファチニブの世界市場規模 ・アファチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・アファチニブのアメリカ市場規模推移 ・アファチニブのカナダ市場規模推移 ・アファチニブのメキシコ市場規模推移 ・アファチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アファチニブのドイツ市場規模推移 ・アファチニブのイギリス市場規模推移 ・アファチニブのロシア市場規模推移 ・アファチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アファチニブの日本市場規模推移 ・アファチニブの中国市場規模推移 ・アファチニブの韓国市場規模推移 ・アファチニブのインド市場規模推移 ・アファチニブの東南アジア市場規模推移 ・アファチニブの南米市場分析（ブラジル、アルゼンチン等） ・アファチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アファチニブの種類別分析/販売量、売上、市場シェア（30mgテーブル、40mgテーブル、50mgテーブル、25mgテーブル、20mgテーブル、その他） ・アファチニブの用途別分析/市場規模（肺、乳房、結腸直腸、黒色腫、前立腺、頭頸部、卵巣、膵臓） ・アファチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アファチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Afatinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Afatinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Afatinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Afatinib, with price, sales, revenue and global market share of Afatinib in 2017 and 2018.
Chapter 3, the Afatinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afatinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Afatinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Afatinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Afatinib Introduction
1.2 Market Analysis by Type
1.2.1 30mg Tables
1.2.2 40mg Tables
1.2.3 50mg Tables
1.2.4 25mg Tables
1.2.5 20mg Tables
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Business Overview
2.1.2 Afatinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Hengrui Medicine
2.2.1 Business Overview
2.2.2 Afatinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hengrui Medicine Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Beacon Pharma
2.3.1 Business Overview
2.3.2 Afatinib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beacon Pharma Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Afatinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Afatinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Afatinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Afatinib Manufacturer Market Share in 2018
3.3.2 Top 6 Afatinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Afatinib Market Analysis by Regions
4.1 Global Afatinib Sales, Revenue and Market Share by Regions
4.1.1 Global Afatinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Afatinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Afatinib Sales and Growth Rate (2014-2019)
4.3 Europe Afatinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Afatinib Sales and Growth Rate (2014-2019)
4.5 South America Afatinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Afatinib Sales and Growth Rate (2014-2019)
5 North America Afatinib by Country
5.1 North America Afatinib Sales, Revenue and Market Share by Country
5.1.1 North America Afatinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Afatinib Revenue and Market Share by Country (2014-2019)
5.2 United States Afatinib Sales and Growth Rate (2014-2019)
5.3 Canada Afatinib Sales and Growth Rate (2014-2019)
5.4 Mexico Afatinib Sales and Growth Rate (2014-2019)
6 Europe Afatinib by Country
6.1 Europe Afatinib Sales, Revenue and Market Share by Country
6.1.1 Europe Afatinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Afatinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Afatinib Sales and Growth Rate (2014-2019)
6.3 UK Afatinib Sales and Growth Rate (2014-2019)
6.4 France Afatinib Sales and Growth Rate (2014-2019)
6.5 Russia Afatinib Sales and Growth Rate (2014-2019)
6.6 Italy Afatinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Afatinib by Country
7.1 Asia-Pacific Afatinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Afatinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Afatinib Revenue and Market Share by Country (2014-2019)
7.2 China Afatinib Sales and Growth Rate (2014-2019)
7.3 Japan Afatinib Sales and Growth Rate (2014-2019)
7.4 Korea Afatinib Sales and Growth Rate (2014-2019)
7.5 India Afatinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Afatinib Sales and Growth Rate (2014-2019)
8 South America Afatinib by Country
8.1 South America Afatinib Sales, Revenue and Market Share by Country
8.1.1 South America Afatinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Afatinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Afatinib Sales and Growth Rate (2014-2019)
8.3 Argentina Afatinib Sales and Growth Rate (2014-2019)
8.4 Colombia Afatinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Afatinib by Countries
9.1 Middle East and Africa Afatinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Afatinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Afatinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Afatinib Sales and Growth Rate (2014-2019)
9.3 Turkey Afatinib Sales and Growth Rate (2014-2019)
9.4 Egypt Afatinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Afatinib Sales and Growth Rate (2014-2019)
9.6 South Africa Afatinib Sales and Growth Rate (2014-2019)
10 Global Afatinib Market Segment by Type
10.1 Global Afatinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Afatinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Afatinib Revenue and Market Share by Type (2014-2019)
10.2 30mg Tables Sales Growth and Price
10.2.1 Global 30mg Tables Sales Growth (2014-2019)
10.2.2 Global 30mg Tables Price (2014-2019)
10.3 40mg Tables Sales Growth and Price
10.3.1 Global 40mg Tables Sales Growth (2014-2019)
10.3.2 Global 40mg Tables Price (2014-2019)
10.4 50mg Tables Sales Growth and Price
10.4.1 Global 50mg Tables Sales Growth (2014-2019)
10.4.2 Global 50mg Tables Price (2014-2019)
10.5 25mg Tables Sales Growth and Price
10.5.1 Global 25mg Tables Sales Growth (2014-2019)
10.5.2 Global 25mg Tables Price (2014-2019)
10.6 20mg Tables Sales Growth and Price
10.6.1 Global 20mg Tables Sales Growth (2014-2019)
10.6.2 Global 20mg Tables Price (2014-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2014-2019)
10.7.2 Global Other Price (2014-2019)
11 Global Afatinib Market Segment by Application
11.1 Global Afatinib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Afatinib Market Forecast (2019-2024)
12.1 Global Afatinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Afatinib Market Forecast by Regions (2019-2024)
12.2.1 North America Afatinib Market Forecast (2019-2024)
12.2.2 Europe Afatinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Afatinib Market Forecast (2019-2024)
12.2.4 South America Afatinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Afatinib Market Forecast (2019-2024)
12.3 Afatinib Market Forecast by Type (2019-2024)
12.3.1 Global Afatinib Sales Forecast by Type (2019-2024)
12.3.2 Global Afatinib Market Share Forecast by Type (2019-2024)
12.4 Afatinib Market Forecast by Application (2019-2024)
12.4.1 Global Afatinib Sales Forecast by Application (2019-2024)
12.4.2 Global Afatinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Afatinib Picture
Table Product Specifications of Afatinib
Figure Global Sales Market Share of Afatinib by Types in 2018
Table Afatinib Types for Major Manufacturers
Figure 30mg Tables Picture
Figure 40mg Tables Picture
Figure 50mg Tables Picture
Figure 25mg Tables Picture
Figure 20mg Tables Picture
Figure Other Picture
Figure Afatinib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Afatinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Afatinib Revenue (Value) and Growth Rate (2014-2024)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Afatinib Type and Applications
Table Boehringer Ingelheim Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine Afatinib Type and Applications
Table Hengrui Medicine Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beacon Pharma Basic Information, Manufacturing Base and Competitors
Table Beacon Pharma Afatinib Type and Applications
Table Beacon Pharma Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Afatinib Sales by Manufacturer (2017-2018)
Figure Global Afatinib Sales Market Share by Manufacturer in 2017
Figure Global Afatinib Sales Market Share by Manufacturer in 2018
Table Global Afatinib Revenue by Manufacturer (2017-2018)
Figure Global Afatinib Revenue Market Share by Manufacturer in 2017
Figure Global Afatinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Afatinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Afatinib Manufacturer (Revenue) Market Share in 2018
Figure Global Afatinib Sales and Growth Rate (2014-2019)
Figure Global Afatinib Revenue and Growth Rate (2014-2019)
Table Global Afatinib Sales by Regions (2014-2019)
Table Global Afatinib Sales Market Share by Regions (2014-2019)
Table Global Afatinib Revenue by Regions (2014-2019)
Figure Global Afatinib Revenue Market Share by Regions (2014-2019)
Figure Global Afatinib Revenue Market Share by Regions in 2018
Figure North America Afatinib Sales and Growth Rate (2014-2019)
Figure Europe Afatinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Afatinib Sales and Growth Rate (2014-2019)
Figure South America Afatinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Afatinib Sales and Growth Rate (2014-2019)
Figure North America Afatinib Revenue and Growth Rate (2014-2019)
Table North America Afatinib Sales by Countries (2014-2019)
Table North America Afatinib Sales Market Share by Countries (2014-2019)
Figure North America Afatinib Sales Market Share by Countries (2014-2019)
Figure North America Afatinib Sales Market Share by Countries in 2018
Table North America Afatinib Revenue by Countries (2014-2019)
Table North America Afatinib Revenue Market Share by Countries (2014-2019)
Figure North America Afatinib Revenue Market Share by Countries (2014-2019)
Figure North America Afatinib Revenue Market Share by Countries in 2018
Figure United States Afatinib Sales and Growth Rate (2014-2019)
Figure Canada Afatinib Sales and Growth Rate (2014-2019)
Figure Mexico Afatinib Sales and Growth Rate (2014-2019)
Figure Europe Afatinib Revenue and Growth Rate (2014-2019)
Table Europe Afatinib Sales by Countries (2014-2019)
Table Europe Afatinib Sales Market Share by Countries (2014-2019)
Table Europe Afatinib Revenue by Countries (2014-2019)
Figure Europe Afatinib Revenue Market Share by Countries (2014-2019)
Figure Europe Afatinib Revenue Market Share by Countries in 2018
Figure Germany Afatinib Sales and Growth Rate (2014-2019)
Figure UK Afatinib Sales and Growth Rate (2014-2019)
Figure France Afatinib Sales and Growth Rate (2014-2019)
Figure Russia Afatinib Sales and Growth Rate (2014-2019)
Figure Italy Afatinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Afatinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Afatinib Sales by Countries (2014-2019)
Table Asia-Pacific Afatinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Afatinib Sales Market Share by Countries 2018
Table Asia-Pacific Afatinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Afatinib Revenue Market Share by Countries 2018
Figure China Afatinib Sales and Growth Rate (2014-2019)
Figure Japan Afatinib Sales and Growth Rate (2014-2019)
Figure Korea Afatinib Sales and Growth Rate (2014-2019)
Figure India Afatinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Afatinib Sales and Growth Rate (2014-2019)
Figure South America Afatinib Revenue and Growth Rate (2014-2019)
Table South America Afatinib Sales by Countries (2014-2019)
Table South America Afatinib Sales Market Share by Countries (2014-2019)
Figure South America Afatinib Sales Market Share by Countries in 2018
Table South America Afatinib Revenue by Countries (2014-2019)
Table South America Afatinib Revenue Market Share by Countries (2014-2019)
Figure South America Afatinib Revenue Market Share by Countries in 2018
Figure Brazil Afatinib Sales and Growth Rate (2014-2019)
Figure Argentina Afatinib Sales and Growth Rate (2014-2019)
Figure Colombia Afatinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Afatinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Afatinib Sales by Countries (2014-2019)
Table Middle East and Africa Afatinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Afatinib Sales Market Share by Countries in 2018
Table Middle East and Africa Afatinib Revenue by Countries (2014-2019)
Table Middle East and Africa Afatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Afatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Afatinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Afatinib Sales and Growth Rate (2014-2019)
Figure UAE Afatinib Sales and Growth Rate (2014-2019)
Figure Egypt Afatinib Sales and Growth Rate (2014-2019)
Figure Nigeria Afatinib Sales and Growth Rate (2014-2019)
Figure South Africa Afatinib Sales and Growth Rate (2014-2019)
Table Global Afatinib Sales by Type (2014-2019)
Table Global Afatinib Sales Share by Type (2014-2019)
Table Global Afatinib Revenue by Type (2014-2019)
Table Global Afatinib Revenue Share by Type (2014-2019)
Figure Global 30mg Tables Sales Growth (2014-2019)
Figure Global 30mg Tables Price (2014-2019)
Figure Global 40mg Tables Sales Growth (2014-2019)
Figure Global 40mg Tables Price (2014-2019)
Figure Global 50mg Tables Sales Growth (2014-2019)
Figure Global 50mg Tables Price (2014-2019)
Figure Global 25mg Tables Sales Growth (2014-2019)
Figure Global 25mg Tables Price (2014-2019)
Figure Global 20mg Tables Sales Growth (2014-2019)
Figure Global 20mg Tables Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Afatinib Sales by Application (2014-2019)
Table Global Afatinib Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Afatinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Afatinib Sales Forecast by Regions (2019-2024)
Table Global Afatinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Afatinib Market Forecast (2019-2024)
Figure Europe Sales Afatinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Afatinib Market Forecast (2019-2024)
Figure South America Sales Afatinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Afatinib Market Forecast (2019-2024)
Table Global Afatinib Sales Forecast by Type (2019-2024)
Table Global Afatinib Market Share Forecast by Type (2019-2024)
Table Global Afatinib Sales Forecast by Application (2019-2024)
Table Global Afatinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
スルファジアジンナトリウム注射の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Sulfadiazine Sodium Injection is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Sulfadiazine Sodium…- アベマシクリブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Abemaciclib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Abemaciclib in global marke…
- カーフィルゾミブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Carfilzomib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Carfilzomib in global marke…
- トレミフェンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Toremifene is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Toremifene in global market,…
- ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…